A dendritic cell targeting NY-ESO-1 vaccine significantly augments early and durable immune responses in melanoma patients pretreated with human Flt-3 Ligand

被引：0

作者：

Bhardwaj, Nina ^{[1
]}

Friedlander, Philip ^{[2
]}

Pavlick, Anna ^{[3
]}

Ernstoff, Marc ^{[4
]}

Gastman, Brian ^{[5
]}

Hanks, Brent ^{[6
]}

Albertini, Mark ^{[7
]}

Luke, Jason ^{[8
]}

Yellin, Michael ^{[9
]}

Keler, Tibor ^{[9
]}

Davis, Thomas ^{[9
]}

Vitale, Laura ^{[9
]}

Blazquez, Ana ^{[10
]}

Morishima, Chihiro ^{[11
]}

Danaher, Patrick ^{[12
]}

Warren, Sarah ^{[12
]}

Salim, Bob ^{[13
]}

Hess, Bruce ^{[11
]}

D'Amico, Leonard ^{[11
]}

Lundgren, Lisa ^{[14
]}

Disis, Nora ^{[11
]}

Cheever, Martin ^{[14
]}

Fling, Steven ^{[14
]}

机构：

[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[2] Mt Sinai Beth Israel, New York, NY USA

[3] NYU Lagone Med Ctr, New York, NY USA

[4] Roswell Pk Canc Inst, Buffalo, NY USA

[5] Cleveland Clin, Cleveland, OH 44106 USA

[6] Duke, Durham, NC USA

[7] Univ Wisconsin, Madison, WI USA

[8] Univ Chicago Med, Chicago, IL USA

[9] Celldex Therapeut, Needham, MA USA

[10] Mt Sinai, New York, NY USA

[11] Univ Washington, Seattle, WA 98195 USA

[12] Nanostring Technol, Seattle, WA USA

[13] Axio Res, Seattle, WA USA

[14] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 43 条

[41] A novel affinity-enhanced NY-ESO-1-targeting TCR-redirected T cell transfer exhibited early-onset cytokine release syndrome and subsequent tumour responses in synovial sarcoma patients
Hattori, H.
Ishihara, M.
Kitano, S.
Miyahara, Y.
Kato, H.
Mishima, H.
Yamamoto, N.
Funakoshi, T.
Kojima, T.
Sasada, T.
Sato, E.
Okamoto, S.
Tomura, D.
Chono, H.
Nukaya, I.
Mineno, J.
Ikeda, H.
Watanabe, T.
Kageyama, S.
Shiku, H.
ANNALS OF ONCOLOGY, 2019, 30 : 481 - 481
[42] Intramuscular (IM) injection of Flt3 ligand (FL) plasmid formulated with a pluronic carrier results in recruitment of dendritic cells (DC) and augmented T cell responses to an HIV-1 gag DNA vaccine
Pisarev, VM
Sang, HX
Chavez, J
Robinson, SN
Talmadge, JE
FASEB JOURNAL, 2002, 16 (05): : A1038 - A1038
[43] Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope
Baumgaertner, P.
Nunes, C. Costa
Cachot, A.
Maby-El Hajjami, H.
Cagnon, L.
Braun, M.
Derre, L.
Rivals, J. -P.
Rimoldi, D.
Gnjatic, S.
Abed Maillard, S.
Marcos Mondejar, P.
Protti, M. P.
Romano, E.
Michielin, O.
Romero, P.
Speiser, D. E.
Jandus, C.
ONCOIMMUNOLOGY, 2016, 5 (10):

← 1 2 3 4 5 →